Asia-Pacific Rare Disease Drug Market Report 2018

February 2018 | 123 pages | ID: A7DBDA275EAEN
QYResearch

Abstracts

In this report, the Asia-Pacific Rare Disease Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Doses), revenue (Million USD), market share and growth rate of Rare Disease Drug for these regions, from 2013 to 2025 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Rare Disease Drug market competition by top manufacturers/players, with Rare Disease Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis AG
• Bristol-Myers Squibb Company
• Celgene Corporation
• F. Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• Sanofi S.A.
• Alexion Pharmaceuticals, Inc.
• Eli Lilly and Company
• Novo Nordisk A/S
• AstraZeneca
• Eisai Co., Ltd.
• Daiichi Sankyo Company Limited
• Bayer AG
• GlaxoSmithKline
• Merck & Co., Inc.
• Johnson & Johnson
• Biogen, Inc.
• Shire
• Amgen, Inc.
• Deciphera
• Atara Biotherapeutics
• ProQR

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into

• >1‰
• 0.65‰～1‰
• <0.1‰

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital Pharmacies
• Speciality Pharmacies
• Retail pharmacies
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Rare Disease Drug Market Report 2018

1 RARE DISEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Rare Disease Drug
1.2 Classification of Rare Disease Drug by Product Category
  1.2.1 Asia-Pacific Rare Disease Drug Market Size (Sales) Comparison by Types (2013-2025)
  1.2.2 Asia-Pacific Rare Disease Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 >1‰
  1.2.4 0.65‰～1‰
  1.2.5 <0.1‰
1.3 Asia-Pacific Rare Disease Drug Market by Application/End Users
  1.3.1 Asia-Pacific Rare Disease Drug Sales (Volume) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Hospital Pharmacies
  1.3.3 Speciality Pharmacies
  1.3.4 Retail pharmacies
  1.3.5 Others
1.4 Asia-Pacific Rare Disease Drug Market by Region
  1.4.1 Asia-Pacific Rare Disease Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 China Status and Prospect (2013-2025)
  1.4.3 Japan Status and Prospect (2013-2025)
  1.4.4 South Korea Status and Prospect (2013-2025)
  1.4.5 Taiwan Status and Prospect (2013-2025)
  1.4.6 India Status and Prospect (2013-2025)
  1.4.7 Southeast Asia Status and Prospect (2013-2025)
  1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Rare Disease Drug (2013-2025)
  1.5.1 Asia-Pacific Rare Disease Drug Sales and Growth Rate (2013-2025)
  1.5.2 Asia-Pacific Rare Disease Drug Revenue and Growth Rate (2013-2025)

2 ASIA-PACIFIC RARE DISEASE DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Rare Disease Drug Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Rare Disease Drug Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Asia-Pacific Rare Disease Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Rare Disease Drug (Volume and Value) by Type
  2.2.1 Asia-Pacific Rare Disease Drug Sales and Market Share by Type (2013-2018)
  2.2.2 Asia-Pacific Rare Disease Drug Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Rare Disease Drug (Volume) by Application
2.4 Asia-Pacific Rare Disease Drug (Volume and Value) by Region
  2.4.1 Asia-Pacific Rare Disease Drug Sales and Market Share by Region (2013-2018)
  2.4.2 Asia-Pacific Rare Disease Drug Revenue and Market Share by Region (2013-2018)

3 CHINA RARE DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 China Rare Disease Drug Sales and Value (2013-2018)
  3.1.1 China Rare Disease Drug Sales Volume and Growth Rate (2013-2018)
  3.1.2 China Rare Disease Drug Revenue and Growth Rate (2013-2018)
  3.1.3 China Rare Disease Drug Sales Price Trend (2013-2018)
3.2 China Rare Disease Drug Sales Volume and Market Share by Type
3.3 China Rare Disease Drug Sales Volume and Market Share by Application

4 JAPAN RARE DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Rare Disease Drug Sales and Value (2013-2018)
  4.1.1 Japan Rare Disease Drug Sales Volume and Growth Rate (2013-2018)
  4.1.2 Japan Rare Disease Drug Revenue and Growth Rate (2013-2018)
  4.1.3 Japan Rare Disease Drug Sales Price Trend (2013-2018)
4.2 Japan Rare Disease Drug Sales Volume and Market Share by Type
4.3 Japan Rare Disease Drug Sales Volume and Market Share by Application

5 SOUTH KOREA RARE DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Rare Disease Drug Sales and Value (2013-2018)
  5.1.1 South Korea Rare Disease Drug Sales Volume and Growth Rate (2013-2018)
  5.1.2 South Korea Rare Disease Drug Revenue and Growth Rate (2013-2018)
  5.1.3 South Korea Rare Disease Drug Sales Price Trend (2013-2018)
5.2 South Korea Rare Disease Drug Sales Volume and Market Share by Type
5.3 South Korea Rare Disease Drug Sales Volume and Market Share by Application

6 TAIWAN RARE DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Rare Disease Drug Sales and Value (2013-2018)
  6.1.1 Taiwan Rare Disease Drug Sales Volume and Growth Rate (2013-2018)
  6.1.2 Taiwan Rare Disease Drug Revenue and Growth Rate (2013-2018)
  6.1.3 Taiwan Rare Disease Drug Sales Price Trend (2013-2018)
6.2 Taiwan Rare Disease Drug Sales Volume and Market Share by Type
6.3 Taiwan Rare Disease Drug Sales Volume and Market Share by Application

7 INDIA RARE DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 India Rare Disease Drug Sales and Value (2013-2018)
  7.1.1 India Rare Disease Drug Sales Volume and Growth Rate (2013-2018)
  7.1.2 India Rare Disease Drug Revenue and Growth Rate (2013-2018)
  7.1.3 India Rare Disease Drug Sales Price Trend (2013-2018)
7.2 India Rare Disease Drug Sales Volume and Market Share by Type
7.3 India Rare Disease Drug Sales Volume and Market Share by Application

8 SOUTHEAST ASIA RARE DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Rare Disease Drug Sales and Value (2013-2018)
  8.1.1 Southeast Asia Rare Disease Drug Sales Volume and Growth Rate (2013-2018)
  8.1.2 Southeast Asia Rare Disease Drug Revenue and Growth Rate (2013-2018)
  8.1.3 Southeast Asia Rare Disease Drug Sales Price Trend (2013-2018)
8.2 Southeast Asia Rare Disease Drug Sales Volume and Market Share by Type
8.3 Southeast Asia Rare Disease Drug Sales Volume and Market Share by Application

9 AUSTRALIA RARE DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Rare Disease Drug Sales and Value (2013-2018)
  9.1.1 Australia Rare Disease Drug Sales Volume and Growth Rate (2013-2018)
  9.1.2 Australia Rare Disease Drug Revenue and Growth Rate (2013-2018)
  9.1.3 Australia Rare Disease Drug Sales Price Trend (2013-2018)
9.2 Australia Rare Disease Drug Sales Volume and Market Share by Type
9.3 Australia Rare Disease Drug Sales Volume and Market Share by Application

10 ASIA-PACIFIC RARE DISEASE DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Novartis AG
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Rare Disease Drug Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Novartis AG Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.1.4 Main Business/Business Overview
10.2 Bristol-Myers Squibb Company
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Rare Disease Drug Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Bristol-Myers Squibb Company Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.2.4 Main Business/Business Overview
10.3 Celgene Corporation
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Rare Disease Drug Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Celgene Corporation Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.3.4 Main Business/Business Overview
10.4 F. Hoffmann-La Roche Ltd.
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Rare Disease Drug Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.4.4 Main Business/Business Overview
10.5 Pfizer, Inc.
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Rare Disease Drug Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Pfizer, Inc. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.5.4 Main Business/Business Overview
10.6 Sanofi S.A.
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Rare Disease Drug Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Sanofi S.A. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.6.4 Main Business/Business Overview
10.7 Alexion Pharmaceuticals, Inc.
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Rare Disease Drug Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.7.4 Main Business/Business Overview
10.8 Eli Lilly and Company
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Rare Disease Drug Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Eli Lilly and Company Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.8.4 Main Business/Business Overview
10.9 Novo Nordisk A/S
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Rare Disease Drug Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Novo Nordisk A/S Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.9.4 Main Business/Business Overview
10.10 AstraZeneca
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Rare Disease Drug Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 AstraZeneca Rare Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.10.4 Main Business/Business Overview
10.11 Eisai Co., Ltd.
10.12 Daiichi Sankyo Company Limited
10.13 Bayer AG
10.14 GlaxoSmithKline
10.15 Merck & Co., Inc.
10.16 Johnson & Johnson
10.17 Biogen, Inc.
10.18 Shire
10.19 Amgen, Inc.
10.20 Deciphera
10.21 Atara Biotherapeutics
10.22 ProQR

11 RARE DISEASE DRUG MANUFACTURING COST ANALYSIS

11.1 Rare Disease Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Rare Disease Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Rare Disease Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Rare Disease Drug Major Manufacturers in 2017
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC RARE DISEASE DRUG MARKET FORECAST (2018-2025)

15.1 Asia-Pacific Rare Disease Drug Sales Volume, Revenue and Price Forecast (2018-2025)
  15.1.1 Asia-Pacific Rare Disease Drug Sales Volume and Growth Rate Forecast (2018-2025)
  15.1.2 Asia-Pacific Rare Disease Drug Revenue and Growth Rate Forecast (2018-2025)
  15.1.3 Asia-Pacific Rare Disease Drug Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Rare Disease Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.1 Asia-Pacific Rare Disease Drug Sales Volume and Growth Rate Forecast by Region (2018-2025)
  15.2.2 Asia-Pacific Rare Disease Drug Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.3 China Rare Disease Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.4 Japan Rare Disease Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.5 South Korea Rare Disease Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.6 Taiwan Rare Disease Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.7 India Rare Disease Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.8 Southeast Asia Rare Disease Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.9 Australia Rare Disease Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Rare Disease Drug Sales, Revenue and Price Forecast by Type (2018-2025)
  15.3.1 Asia-Pacific Rare Disease Drug Sales Forecast by Type (2018-2025)
  15.3.2 Asia-Pacific Rare Disease Drug Revenue Forecast by Type (2018-2025)
  15.3.3 Asia-Pacific Rare Disease Drug Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Rare Disease Drug Sales Forecast by Application (2018-2025)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Rare Disease Drug
Figure Asia-Pacific Rare Disease Drug Sales Volume (K Doses) by Type (2013-2025)
Figure Asia-Pacific Rare Disease Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure >1‰ Product Picture
Figure 0.65‰～1‰ Product Picture
Figure <0.1‰ Product Picture
Figure Asia-Pacific Rare Disease Drug Sales (K Doses) by Application (2013-2025)
Figure Asia-Pacific Sales Market Share of Rare Disease Drug by Application in 2017
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Speciality Pharmacies Examples
Table Key Downstream Customer in Speciality Pharmacies
Figure Retail pharmacies Examples
Table Key Downstream Customer in Retail pharmacies
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Rare Disease Drug Market Size (Million USD) by Region (2013-2025)
Figure China Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure South Korea Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Taiwan Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Australia Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Rare Disease Drug Sales Volume (K Doses) and Growth Rate (2013-2025)
Figure Asia-Pacific Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Rare Disease Drug Market Major Players Product Sales Volume (K Doses)(2013-2018)
Table Asia-Pacific Rare Disease Drug Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table Asia-Pacific Rare Disease Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Rare Disease Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Rare Disease Drug Sales Share by Players/Suppliers
Figure Asia-Pacific Rare Disease Drug Market Major Players Product Revenue (Million USD) 2013-2018
Table Asia-Pacific Rare Disease Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Asia-Pacific Rare Disease Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Rare Disease Drug Revenue Share by Players
Figure 2017 Asia-Pacific Rare Disease Drug Revenue Share by Players
Table Asia-Pacific Rare Disease Drug Sales and Market Share by Type (2013-2018)
Table Asia-Pacific Rare Disease Drug Sales Share by Type (2013-2018)
Figure Sales Market Share of Rare Disease Drug by Type (2013-2018)
Figure Asia-Pacific Rare Disease Drug Sales Growth Rate by Type (2013-2018)
Table Asia-Pacific Rare Disease Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Asia-Pacific Rare Disease Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Rare Disease Drug by Type (2013-2018)
Figure Asia-Pacific Rare Disease Drug Revenue Growth Rate by Type (2013-2018)
Table Asia-Pacific Rare Disease Drug Sales Volume (K Doses) and Market Share by Region (2013-2018)
Table Asia-Pacific Rare Disease Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Rare Disease Drug by Region (2013-2018)
Figure Asia-Pacific Rare Disease Drug Sales Market Share by Region in 2017
Table Asia-Pacific Rare Disease Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Asia-Pacific Rare Disease Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Rare Disease Drug by Region (2013-2018)
Figure Asia-Pacific Rare Disease Drug Revenue Market Share by Region in 2017
Table Asia-Pacific Rare Disease Drug Sales Volume (K Doses) and Market Share by Application (2013-2018)
Table Asia-Pacific Rare Disease Drug Sales Share (%) by Application (2013-2018)
Figure Asia-Pacific Rare Disease Drug Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Rare Disease Drug Sales Market Share by Application (2013-2018)
Figure China Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure China Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Rare Disease Drug Sales Price (USD/Dose) Trend (2013-2018)
Table China Rare Disease Drug Sales Volume (K Doses) by Type (2013-2018)
Table China Rare Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure China Rare Disease Drug Sales Volume Market Share by Type in 2017
Table China Rare Disease Drug Sales Volume (K Doses) by Applications (2013-2018)
Table China Rare Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure China Rare Disease Drug Sales Volume Market Share by Application in 2017
Figure Japan Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Japan Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Rare Disease Drug Sales Price (USD/Dose) Trend (2013-2018)
Table Japan Rare Disease Drug Sales Volume (K Doses) by Type (2013-2018)
Table Japan Rare Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Rare Disease Drug Sales Volume Market Share by Type in 2017
Table Japan Rare Disease Drug Sales Volume (K Doses) by Applications (2013-2018)
Table Japan Rare Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Rare Disease Drug Sales Volume Market Share by Application in 2017
Figure South Korea Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure South Korea Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure South Korea Rare Disease Drug Sales Price (USD/Dose) Trend (2013-2018)
Table South Korea Rare Disease Drug Sales Volume (K Doses) by Type (2013-2018)
Table South Korea Rare Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure South Korea Rare Disease Drug Sales Volume Market Share by Type in 2017
Table South Korea Rare Disease Drug Sales Volume (K Doses) by Applications (2013-2018)
Table South Korea Rare Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure South Korea Rare Disease Drug Sales Volume Market Share by Application in 2017
Figure Taiwan Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Taiwan Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Taiwan Rare Disease Drug Sales Price (USD/Dose) Trend (2013-2018)
Table Taiwan Rare Disease Drug Sales Volume (K Doses) by Type (2013-2018)
Table Taiwan Rare Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure Taiwan Rare Disease Drug Sales Volume Market Share by Type in 2017
Table Taiwan Rare Disease Drug Sales Volume (K Doses) by Applications (2013-2018)
Table Taiwan Rare Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure Taiwan Rare Disease Drug Sales Volume Market Share by Application in 2017
Figure India Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure India Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Rare Disease Drug Sales Price (USD/Dose) Trend (2013-2018)
Table India Rare Disease Drug Sales Volume (K Doses) by Type (2013-2018)
Table India Rare Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure India Rare Disease Drug Sales Volume Market Share by Type in 2017
Table India Rare Disease Drug Sales Volume (K Doses) by Application (2013-2018)
Table India Rare Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure India Rare Disease Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Southeast Asia Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Rare Disease Drug Sales Price (USD/Dose) Trend (2013-2018)
Table Southeast Asia Rare Disease Drug Sales Volume (K Doses) by Type (2013-2018)
Table Southeast Asia Rare Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Rare Disease Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Rare Disease Drug Sales Volume (K Doses) by Applications (2013-2018)
Table Southeast Asia Rare Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Rare Disease Drug Sales Volume Market Share by Application in 2017
Figure Australia Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Australia Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Australia Rare Disease Drug Sales Price (USD/Dose) Trend (2013-2018)
Table Australia Rare Disease Drug Sales Volume (K Doses) by Type (2013-2018)
Table Australia Rare Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure Australia Rare Disease Drug Sales Volume Market Share by Type in 2017
Table Australia Rare Disease Drug Sales Volume (K Doses) by Applications (2013-2018)
Table Australia Rare Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure Australia Rare Disease Drug Sales Volume Market Share by Application in 2017
Table Novartis AG Rare Disease Drug Basic Information List
Table Novartis AG Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Novartis AG Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Novartis AG Rare Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Novartis AG Rare Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Bristol-Myers Squibb Company Rare Disease Drug Basic Information List
Table Bristol-Myers Squibb Company Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Company Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company Rare Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Bristol-Myers Squibb Company Rare Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Celgene Corporation Rare Disease Drug Basic Information List
Table Celgene Corporation Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Celgene Corporation Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Celgene Corporation Rare Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Celgene Corporation Rare Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table F. Hoffmann-La Roche Ltd. Rare Disease Drug Basic Information List
Table F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Rare Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Pfizer, Inc. Rare Disease Drug Basic Information List
Table Pfizer, Inc. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Pfizer, Inc. Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Pfizer, Inc. Rare Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Pfizer, Inc. Rare Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Sanofi S.A. Rare Disease Drug Basic Information List
Table Sanofi S.A. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sanofi S.A. Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Sanofi S.A. Rare Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Sanofi S.A. Rare Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Alexion Pharmaceuticals, Inc. Rare Disease Drug Basic Information List
Table Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Alexion Pharmaceuticals, Inc. Rare Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Eli Lilly and Company Rare Disease Drug Basic Information List
Table Eli Lilly and Company Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Eli Lilly and Company Rare Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Eli Lilly and Company Rare Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Novo Nordisk A/S Rare Disease Drug Basic Information List
Table Novo Nordisk A/S Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Novo Nordisk A/S Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure Novo Nordisk A/S Rare Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Novo Nordisk A/S Rare Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table AstraZeneca Rare Disease Drug Basic Information List
Table AstraZeneca Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure AstraZeneca Rare Disease Drug Sales (K Doses) and Growth Rate (2013-2018)
Figure AstraZeneca Rare Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure AstraZeneca Rare Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Eisai Co., Ltd. Rare Disease Drug Basic Information List
Table Daiichi Sankyo Company Limited Rare Disease Drug Basic Information List
Table Bayer AG Rare Disease Drug Basic Information List
Table GlaxoSmithKline Rare Disease Drug Basic Information List
Table Merck & Co., Inc. Rare Disease Drug Basic Information List
Table Johnson & Johnson Rare Disease Drug Basic Information List
Table Biogen, Inc. Rare Disease Drug Basic Information List
Table Shire Rare Disease Drug Basic Information List
Table Amgen, Inc. Rare Disease Drug Basic Information List
Table Deciphera Rare Disease Drug Basic Information List
Table Atara Biotherapeutics Rare Disease Drug Basic Information List
Table ProQR Rare Disease Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Dose) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rare Disease Drug
Figure Manufacturing Process Analysis of Rare Disease Drug
Figure Rare Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Rare Disease Drug Major Manufacturers in 2017
Table Major Buyers of Rare Disease Drug
Table Distributors/Traders List
Figure Asia-Pacific Rare Disease Drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Rare Disease Drug Price (USD/Dose) and Trend Forecast (2018-2025)
Table Asia-Pacific Rare Disease Drug Sales Volume (K Doses) Forecast by Region (2018-2025)
Figure Asia-Pacific Rare Disease Drug Sales Volume Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Rare Disease Drug Sales Volume Market Share Forecast by Region in 2025
Table Asia-Pacific Rare Disease Drug Revenue (Million USD) Forecast by Region (2018-2025)
Figure Asia-Pacific Rare Disease Drug Revenue Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Rare Disease Drug Revenue Market Share Forecast by Region in 2025
Figure China Rare Disease Drug Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure China Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Rare Disease Drug Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure Japan Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure South Korea Rare Disease Drug Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure South Korea Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Taiwan Rare Disease Drug Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure Taiwan Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Rare Disease Drug Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure India Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Rare Disease Drug Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Australia Rare Disease Drug Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure Australia Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Rare Disease Drug Sales (K Doses) Forecast by Type (2018-2025)
Figure Asia-Pacific Rare Disease Drug Sales Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Rare Disease Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Asia-Pacific Rare Disease Drug Revenue Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Rare Disease Drug Price (USD/Dose) Forecast by Type (2018-2025)
Table Asia-Pacific Rare Disease Drug Sales (K Doses) Forecast by Application (2018-2025)
Figure Asia-Pacific Rare Disease Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources